Dr. Uri Ilan, pediatric oncologist at The Princess Máxima Center for Pediatric Oncology explains: “The power to provide reports summarizing all relevant information in the literature to tumor boards is remarkable. We’re now working with partners to develop similar systems for Neuro-Oncology and Neuroblastoma.”
Other systems like Rutgers Health are now expanding upon this foundation. Dr. David J. Foran, Chief Informatics Officer, who leads the Rutgers team, notes: “Rutgers Cancer Institute is poised to integrate Capricorn with our tumor boards to enable us to access these AI-powered oncology tools and evaluate the performance of the underlying algorithms for personalizing treatment for cancer patients. We will also assess its potential use in our global health initiatives in Botswana.”
Combining PubMed with BigQuery unlocks new healthcare capabilities
Healthcare organizations are discovering other transformative use cases by combining PubMed’s comprehensive medical literature with BigQuery’s analytics and AI capabilities:
Clinical decision support: Leading pediatric hospitals may use semantic search to match leukemia patients with relevant clinical trials based on complete genetic profiles. Continued collaboration and knowledge sharing through these tools will be essential for advancing precision medicine.
Drug discovery and repurposing: Pharmaceutical companies analyze literature patterns to identify existing drugs that could treat new conditions. Research indicates repurposed drugs cost 80% less and reach the market 70% faster, and health economist Federico Felizzi highlights that machine learning also helps refine the economic assessments needed to validate these candidates. Analyzing citation patterns between drugs can identify thousands of repurposing candidates, transforming a years-long manual process into automated discovery.
Public services: Government health agencies like the FDA can use this repository to synthesize evidence on drug efficacy and food safety, streamlining approvals to ensure a safe domestic food and drug supply while accelerating new therapies and proactively identifying trends in food safety and nutrition to combat chronic disease.
Rare disease diagnosis: Medical institutions can now match complex symptom patterns against global case reports, potentially reducing diagnostic time from years to months for the 300 million people affected by rare diseases.
Insurance and payer intelligence: American and European bodies like Germany’s G-BA, UK’s NICE, and France’s HAS leverage comprehensive literature analysis for evidence-based coverage decisions, with literature reviews forming the foundation for health technology assessments and reimbursement decisions across both US and EU markets.
Getting started with PubMed data in BigQuery
Healthcare organizations can immediately begin leveraging PubMed data in BigQuery. Here’s a simple example of how to perform semantic search on medical literature.
After first enabling the Vertex AI API in your Google Cloud project, inside of BigQuery, create a model for text embeddings.
Source Credit: https://cloud.google.com/blog/topics/public-sector/accelerate-medical-research-with-pubmed-data-now-available-in-bigquery/
About the Author
